Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
Top Cited Papers
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 117 (6), 1102-1112.e1
- https://doi.org/10.1016/j.ophtha.2010.02.021
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionPublished by Wiley ,2009
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical StimulatorMolecular Therapy, 2008
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Pathogenesis of Macular Edema With Branch Retinal Vein Occlusion and Intraocular Levels of Vascular Endothelial Growth Factor and Interleukin-6American Journal of Ophthalmology, 2005
- Intravitreal Sustained Release of VEGF Causes Retinal Neovascularization in Rabbits and Breakdown of the Blood– Retinal Barrier in Rabbits and PrimatesExperimental Eye Research, 1997
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Dynamic balanced randomization for clinical trialsStatistics in Medicine, 1993
- Histopathologic Study of Nine Branch Retinal Vein OcclusionsArchives of Ophthalmology (1950), 1982